Clinical Trial Update: Clinical Trial of YYD701-2 for Treatment of Nasolabial Folds [Phase 3]

View source ↗

Summary

Phase 3 clinical trial of YYD701-2 for nasolabial folds has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasolabial Folds Wrinkle Treatment

Drugs mentioned

• YYD701-2

Snippet

Sponsor: Yooyoung Pharmaceutical Co., Ltd. | Conditions: Wrinkle Severity Rating Scale(WSRS) Grade 3 (Moderate) or 4 (Severe) of Nasolabial Folds | Phase 3 | Status: COMPLETED